VML Health urges marketers to shift from lifespan to ‘joyspan’ as patient goals evolve
VML Health has published a report about 10 trends defining the future of healthcare, making the case that pharma marketers must adapt to patients shifting their goals from lifespan to “joyspan.”

VML Health, a leading healthcare consultancy, has recently published a comprehensive report outlining 10 trends that will shape the future of the healthcare industry. Central to this report is the idea that pharma marketers must adapt to a significant shift in patient priorities, moving from a focus on lifespan to a new concept known as “joyspan.” This evolution in patient goals reflects a growing demand for healthcare solutions that not only prolong life but also enhance the quality of life, enabling individuals to experience joy and fulfillment in their daily lives.
The report highlights that traditional marketing strategies, which have historically centered around longevity, are becoming increasingly outdated. As patients become more health-conscious and proactive in managing their well-being, they are increasingly seeking treatments and therapies that allow them to lead richer, more enjoyable lives. This shift is driven by advancements in healthcare technology, increased awareness of preventive care, and a greater emphasis on mental health and overall well-being.
One of the key trends identified in the report is the rise of personalized medicine. As genetic testing and biomarker analysis become more accessible, patients are able to tailor their healthcare approaches to their individual needs. This personalization extends beyond pharmaceuticals, encompassing lifestyle modifications, dietary changes, and mental health interventions. Marketers must embrace this trend and develop strategies that cater to the diverse and evolving needs of their target audiences.
Another significant trend is the growing importance of mental health. The report emphasizes that patients are no longer just seeking treatments for physical ailments but are also prioritizing their emotional and psychological well-being. This shift is reflected in the increasing demand for therapies that address mental health conditions such as depression and anxiety. Pharma marketers must recognize the interconnectedness of physical and mental health and develop integrated approaches that address both aspects.
The report also underscores the role of technology in transforming healthcare. Wearable devices, telemedicine, and digital health platforms are becoming increasingly prevalent, enabling patients to monitor their health more closely and engage in proactive care management. Marketers must leverage these technologies to create engaging and accessible healthcare experiences that resonate with their target audiences.
Furthermore, the report highlights the importance of sustainability in healthcare. Patients are becoming more environmentally conscious, and this trend is influencing their healthcare choices. Marketers must ensure that their products and services align with sustainable practices, from eco-friendly packaging to environmentally responsible manufacturing processes.
In addition to these trends, the report also addresses the growing role of patient-centered care. Patients are increasingly demanding more control over their healthcare decisions and are seeking providers who prioritize their needs and preferences. Marketers must adapt their strategies to place patients at the center of their messaging and offer solutions that empower individuals to take charge of their health.
The concept of “joyspan” is not merely a marketing term; it reflects a deeper cultural shift in how society perceives health and well-being. As people live longer and healthier lives, the focus on lifespan alone becomes less relevant. Instead, there is a growing appreciation for the quality of life, the experiences one can have, and the joy derived from daily activities. This shift is driving healthcare providers, insurers, and pharmaceutical companies to reevaluate their approaches and offer solutions that enhance the joys of living.
In conclusion, VML Health's report serves as a stark warning for pharma marketers to adapt to the evolving needs of their patients. The days of focusing solely on lifespan are coming to an end, and marketers who fail to embrace the “joyspan” concept risk becoming irrelevant in a rapidly changing healthcare landscape. By prioritizing personalized medicine, mental health, technology, sustainability, and patient-centered care, marketers can position themselves at the forefront of the future of healthcare, ensuring they remain relevant and effective in meeting the needs of their audiences.







